Medicare Enrolled
Dr. Nelly Kazzaz, MD
Cardiovascular Disease · Liverpool, NY
Practice pattern: Remote & Cardiac
— Practice combining remote and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kazzaz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kazzaz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kazzaz
Dr. Nelly Kazzaz is a cardiovascular disease specialist in Liverpool, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kazzaz performed 5,104 Medicare services across 3,498 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kazzaz received a total of $5,940 from 35 pharmaceutical and/or device companies across 370 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kazzaz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 12% volume in NY
$5,940 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,104
Medicare services
Top 12% in NY for cardiovascular disease
3,498
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~255 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,294 | $88 | $155 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
666 | $9 | $65 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
418 | $128 | $496 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
397 | $19 | $56 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
392 | $19 | $25 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
321 | $19 | $60 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
251 | $21 | $75 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
232 | $24 | $32 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
188 | $6 | $24 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
175 | $126 | $346 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
124 | $46 | $300 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
115 | $26 | $130 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
114 | $321 | $1,000 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
86 | $66 | $105 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
55 | $112 | $230 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
46 | $55 | $135 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
30 | $19 | $55 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
29 | $39 | $225 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
29 | $18 | $225 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
27 | $12 | $95 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
27 | $12 | $110 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
27 | $88 | $255 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
25 | $14 | $30 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
23 | $168 | $525 |
| Insertion of implantable heart rhythm monitor A small device is placed under the skin to continuously record the heart's electrical activity. This helps detect irregular heart rhythms that may not appear during a standard office visit. |
13 | $3,299 | $10,000 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
15.9% high complexity
21.3% medium
62.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,940
Total received (2018-2024)
Avg $849/year across 7 years
Top 28% in NY for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
370
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,940 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$908
2023
$1,105
2022
$984
2021
$676
2020
$510
2019
$788
2018
$969
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$321
E.R. Squibb & Sons, L.L.C.
$88
Kiniksa Pharmaceuticals International, plc
$85
Boston Scientific Corporation
$77
Amgen Inc.
$72
Merck Sharp & Dohme LLC
$43
Actelion Pharmaceuticals US, Inc.
$43
Janssen Pharmaceuticals, Inc
$34
Novo Nordisk Inc
$29
Medtronic, Inc.
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$20
SCPHARMACEUTICALS INC.
$19
Regeneron Healthcare Solutions, Inc.
$17
Lexicon Pharmaceuticals, Inc.
$16
Top 3 companies account for 54.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$923
Amgen Inc.
$807
Janssen Pharmaceuticals, Inc
$601
E.R. Squibb & Sons, L.L.C.
$510
Boston Scientific Corporation
$425
BIOTRONIK INC.
$316
PFIZER INC.
$250
Regeneron Healthcare Solutions, Inc.
$245
Amarin Pharma Inc.
$237
SANOFI-AVENTIS U.S. LLC
$221
Merck Sharp & Dohme LLC
$184
Abbott Laboratories
$131
Edwards Lifesciences Corporation
$119
Actelion Pharmaceuticals US, Inc.
$90
Bayer HealthCare Pharmaceuticals Inc.
$88
Boehringer Ingelheim Pharmaceuticals, Inc.
$87
Kiniksa Pharmaceuticals International, plc
$85
AstraZeneca Pharmaceuticals LP
$73
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$67
Medtronic Vascular, Inc.
$63
Kiniksa Pharmaceuticals, Ltd.
$47
Allergan Inc.
$46
Novo Nordisk Inc
$42
Medtronic, Inc.
$41
Alnylam Pharmaceuticals Inc.
$40
Lexicon Pharmaceuticals, Inc.
$34
SCPHARMACEUTICALS INC.
$32
GENZYME CORPORATION
$24
iRhythm Technologies, Inc.
$22
AngioDynamics, Inc.
$20
Astellas Pharma US Inc
$18
Akcea Therapeutics, Inc.
$16
Kowa Pharmaceuticals America, Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$13
Gilead Sciences, Inc.
$11
Top 3 companies account for 39.3% of all-time payments
Associated products mentioned in payments ›
ALPHAVAC · Adempas · Arcalyst · Assurity Pacemaker · BRILINTA · BYSTOLIC · CAMZYOS · CONFIRM RX · CardioMEMS HF System · Claria MRI · ClosureFast · Corlanor · ELIQUIS · EMBLEM · ENTRESTO · EVKEEZA · Edarbi · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FABRAZYME · FARXIGA · FUROSCIX · GENERAL BRADY · GENERAL TACHY · GENERAL - THERAPIES · Inpefa · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LINQ II · LifeVest · Livalo · MICRA · MULTAQ · ONPATTRO · OPSUMIT · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Quartet CRT Lead · Repatha · Reveal LINQ · TEGSEDI · UPTRAVI · VERQUVO · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
71
Per 100K population
15.1
County median income
$74,740
Nearest hospital
ST JOSEPH'S HOSPITAL HEALTH CENTER
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kazzaz is a remote & cardiac specialist, with above-average Medicare volume (top 12% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kazzaz experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kazzaz performed 1,294 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kazzaz receive payments from pharmaceutical companies?
Yes. Dr. Kazzaz received a total of $5,940 from 35 companies across 370 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kazzaz's costs compare to other cardiologists in Liverpool?
Dr. Kazzaz's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kazzaz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Liverpool
Browse cardiologists in Liverpool ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NY
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NY
Which NY cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology